NFIL3 Contributes to Cytotoxic T Lymphocyte-mediated Killing
Overview
Authors
Affiliations
Cytotoxic T lymphocytes (CTLs) are key effectors of the adaptive immune system that recognize and eliminate virally infected and cancerous cells. In naive CD8 T cells, T-cell receptor (TCR) engagement drives a number of transcriptional, translational and proliferation changes over the course of hours and days leading to differentiation into CTLs. To gain a better insight into this mechanism, we compared the transcriptional profiles of naive CD8 T cells to those of activated CTLs. To find new regulators of CTL function, we performed a selective clustered regularly interspaced short palindromic repeats (CRISPR) screen on upregulated genes and identified nuclear factor IL-3 (NFIL3) as a potential regulator of cytotoxicity. Although NFIL3 has established roles in several immune cells including natural killer, Treg, dendritic and CD4 T cells, its function in CD8 CTLs is less well understood. Using CRISPR/Cas9 editing, we found that removing NFIL3 in CTLs resulted in a marked decrease in cytotoxicity. We found that in CTLs lacking NFIL3 TCR-induced extracellular signal-regulated kinase phosphorylation, immune synapse formation and granule release were all intact while cytotoxicity was functionally impaired . Strikingly, NFIL3 controls the production of cytolytic proteins as well as effector cytokines. Thus, NFIL3 plays a cell intrinsic role in modulating cytolytic mechanisms in CTLs.
NarenYa , Feng Y, Su Y, Chen L, Liu Y, Sun Z Brain Behav. 2025; 15(3):e70371.
PMID: 40022169 PMC: 11870834. DOI: 10.1002/brb3.70371.
The Impact of Cell-Intrinsic STAT6 Protein on Donor T Cell-Mediated Graft-Versus-Tumor Effect.
Guan X, Fury H, Issuree P, Atagozli T, McManimon E, Shao P Int J Mol Sci. 2025; 26(1.
PMID: 39796136 PMC: 11719522. DOI: 10.3390/ijms26010280.
NFIL3 contributes to cytotoxic T lymphocyte-mediated killing.
Douanne T, Strege K, Del Castillo Velasco-Herrera M, Rochussen A, Adams D, Griffiths G Open Biol. 2024; 14(2):230456.
PMID: 38412963 PMC: 10898977. DOI: 10.1098/rsob.230456.